Bank Of America Corp Crispr Therapeutics Ag Put Options Transaction History

Bank Of America Corp

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$60.67 - $89.12 $728,040 - $1.07 Million	12,000 Added 31.58%	50,000 $3.41 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $973,223 - $1.82 Million	25,200 Added 196.88%	38,000 $2.38 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $556,416 - $867,456	12,800 New	12,800 $718,000
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $11.9 Million - $16.3 Million	194,600 Added 40.23%	678,300 $44.3 Million
Q2 2022 Aug 12, 2022	BUY	$43.23 - $73.83 $20.9 Million - $35.7 Million	483,600 Added 483600.0%	483,700 $29.4 Million
Q1 2022 May 16, 2022	SELL	$53.19 - $79.24 $5.78 Million - $8.61 Million	-108,600 Reduced 99.91%	100 $6,000
Q4 2021 Feb 08, 2022	SELL	$70.09 - $111.29 $22.9 Million - $36.4 Million	-326,900 Reduced 75.05%	108,700 $8.24 Million
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $23.2 Million - $33 Million	210,800 Added 93.77%	435,600 $48.8 Million
Q2 2021 Sep 13, 2021	BUY	$100.84 - $161.89 $22.7 Million - $36.4 Million	224,800 New	224,800 $36.4 Million

523

58M

1.73M

1.84M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.82B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.